These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32843693)

  • 21. The activated partial thromboplastin time-clot waveform analysis in hemophilia: Does it help in differentiation?
    Mannan KA; Kumar N; Ahluwalia J; Hans C; Kler A; Prakash G; Jain R
    Int J Lab Hematol; 2023 Apr; 45(2):241-249. PubMed ID: 36495061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.
    Dempfle CE; Lorenz S; Smolinski M; Wurst M; West S; Houdijk WP; Quintel M; Borggrefe M
    Crit Care Med; 2004 Feb; 32(2):520-4. PubMed ID: 14758173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Hemodilution on Clot Waveform Analysis Parameters, Clotting Factors, and Thrombin Generation Assays in a Dilutional Model Based on Analysis of 11 Healthy Male Blood Donors.
    Ichikawa J; Okazaki R; Fukuda T; Yoon D; Komori M
    Med Sci Monit; 2022 Oct; 28():e937368. PubMed ID: 36225091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of Clot Waveform Analysis in Russell's Viper Bite Victims with Hematotoxicity.
    Abraham SV; Rafi AM; Krishnan SV; Palatty BU; Innah SJ; Johny J; Varghese S
    J Emerg Trauma Shock; 2018; 11(3):211-216. PubMed ID: 30429630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of hemostatic abnormalities in patients who underwent major hepatobiliary pancreatic surgery using activated partial thromboplastin time-clot waveform analysis.
    Maeda K; Wada H; Shinkai T; Tanemura A; Matsumoto T; Mizuno S
    Thromb Res; 2021 May; 201():154-160. PubMed ID: 33862519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clot Waveform Analysis for Hemostatic Abnormalities.
    Wada H; Shiraki K; Matsumoto T; Shimpo H; Shimaoka M
    Ann Lab Med; 2023 Nov; 43(6):531-538. PubMed ID: 37387486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clot waveform analysis: Where do we stand in 2017?
    Sevenet PO; Depasse F
    Int J Lab Hematol; 2017 Dec; 39(6):561-568. PubMed ID: 28876509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on the Clot Waveform Analysis.
    Wada H; Matsumoto T; Ohishi K; Shiraki K; Shimaoka M
    Clin Appl Thromb Hemost; 2020; 26():1076029620912027. PubMed ID: 32862666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance and Interpretation of Clot Waveform Analysis.
    Ruberto MF; Marongiu F; Barcellona D
    Methods Mol Biol; 2023; 2663():163-173. PubMed ID: 37204709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Factor VIII Concentrates Using Clot Waveform Analysis.
    Wada H; Shiraki K; Matsumoto T; Shimpo H; Sakano Y; Nishii H; Tamaki S; Suzuki K; Tawara I; Yamashita Y; Shimaoka M
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999423
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of in vitro effects of direct thrombin inhibitors and activated factor X inhibitors through clot waveform analysis.
    Wakui M; Fujimori Y; Katagiri H; Nakamura S; Kondo Y; Kuroda Y; Nakagawa T; Shimizu N; Murata M
    J Clin Pathol; 2019 Mar; 72(3):244-250. PubMed ID: 30518630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective comparison of standard clotting tests and novel clot waveform parameters in dogs using the turbidimetric ACL-TOP CTS 300 coagulation analyzer.
    Yagneswar H; Todd JM; Sharkey LC; Rendahl A; Tart K
    J Vet Diagn Invest; 2018 Nov; 30(6):868-877. PubMed ID: 30204058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the phenotypic severity of hemophilia A: using rotational thromboelastometry (ROTEM) and APTT-clot waveform analysis.
    Gupta D; Arya V; Dass J; Gupta N; Kalra M; Sachdeva A; Kotwal J
    Blood Res; 2024 May; 59(1):19. PubMed ID: 38743166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis.
    Kanouchi K; Narimatsu H; Shirata T; Morikane K
    Health Sci Rep; 2021 Jun; 4(2):e258. PubMed ID: 33738342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis.
    Fukui S; Wada H; Ikeda K; Kobayashi M; Shimada Y; Nakazawa Y; Mizutani H; Ichikawa Y; Nishiura Y; Moritani I; Yamanaka Y; Inoue H; Shimaoka M; Shimpo H; Shiraki K
    Clin Appl Thromb Hemost; 2024; 30():10760296241246002. PubMed ID: 38591954
    [No Abstract]   [Full Text] [Related]  

  • 36. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M; Fujimori Y; Nakamura S; Kondo Y; Kuroda Y; Oka S; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2019 Dec; 72(12):817-824. PubMed ID: 31366633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): Interference of C-reactive protein.
    Liu J; Li F; Shu K; Chen T; Wang X; Xie Y; Li S; Zhang Z; Jin S; Jiang M
    J Clin Lab Anal; 2018 Oct; 32(8):e22571. PubMed ID: 29756266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin and Other Common Biomarkers Do Not Reliably Identify Patients at Risk for Bacterial Infection After Congenital Heart Surgery.
    D'Souza S; Guhadasan R; Jennings R; Siner S; Paulus S; Thorburn K; Chesters C; Downey C; Baines P; Lane S; Carrol E
    Pediatr Crit Care Med; 2019 Mar; 20(3):243-251. PubMed ID: 30575697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Assessment of Factor VIII Activity by Template Matching Utilizing Weighted Average Parameters from Comprehensive Clot Waveform Analysis.
    Shimonishi N; Ogiwara K; Oda Y; Kawabe T; Okazaki S; Shima M; Nogami K
    Thromb Haemost; 2021 Feb; 121(2):164-173. PubMed ID: 32828071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clot Waveform Analysis Demonstrates Low Blood Coagulation Ability in Patients with Idiopathic Thrombocytopenic Purpura.
    Wada H; Ichikawa Y; Ezaki M; Shiraki K; Moritani I; Yamashita Y; Matsumoto T; Masuya M; Tawara I; Shimpo H; Shimaoka M
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.